Neurocognitive Functioning in Long-term Survivors of Glioblastoma, IDH-wildtype and Astrocytoma, IDH-mutant, CNS WHO grade 4: a report from EORTC 1419 (ETERNITY)

A Josephine Drijver

doi:10.1016/j.ejca.2026.116985

Neurocognitive Functioning in Long-term Survivors of Glioblastoma, IDH-wildtype and Astrocytoma, IDH-mutant, CNS WHO grade 4: a report from EORTC 1419 (ETERNITY)

2026-08-12

0

OA

AI

A

A Josephine Drijver

E

Elke Butterbrod

C

Caroline Hertler

S

Sé M. Frances

G

Guido Reifenberger

J

Jörg Felsberg

T

Thierry Gorlia

E

Emmie M.C. van den Dobbelsteen

N

Noor de Boer

R

Roberta Rudà

A

Alessia Pellerino

J

Jennifer Clarke

K

Karishma Kumar-Wessel

É

Émeline Tabouret

O

Oliver Schnell

W

Wolfgang Wick

A

Amélie Darlix

G

Giuseppe Lombardi

M

Martin van den Bent

F

François Ducray

DOI：10.1016/j.ejca.2026.116985

Original

Save

View PDF

Abstract

En 中文

• 78% of long-term grade 4 glioma survivors experience cognitive impairment • Neurocognitive performance is linked to tumor location and molecular features • Tailored patient counseling is needed to support long-term quality of life

Keywords:

Glioblastoma

Neurocognitive functioning

long-term survivors

Neurocognitive Functioning in Long-term Survivors of Glioblastoma, IDH-wildtype and Astrocytoma, IDH-mutant, CNS WHO grade 4: a report from EORTC 1419 (ETERNITY)

Abstract

AI Summary

Journal

Organization